References
- Alli, E., Sharma, V.B., Hartman, A.R., Lin, P.S., McPherson, L., and Ford, J.M. (2011). Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells. BMC Pharmacol. 11, 7.
- Annunziata, C.M., and Bates, S.E. (2010). PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer. F1000 Biol. Rep. 2.
- Borysov, S.I., Granic, A., Padmanabhan, J., Walczak, C.E., and Potter, H. (2011). Alzheimer Abeta disrupts the mitotic spindle and directly inhibits mitotic microtubule motors. Cell Cycle 10, 1397-1410. https://doi.org/10.4161/cc.10.9.15478
- Campalans, A., Kortulewski, T., Amouroux, R., Menoni, H., Vermeulen, W., and Radicella, J.P. (2013). Distinct spatiotemporal patterns and PARP dependence of XRCC1 recruitment to single-strand break and base excision repair. Nucleic Acids Res. 41, 3115-3129. https://doi.org/10.1093/nar/gkt025
- Farmer, H., McCabe, N., Lord, C.J., Tutt, A.N., Johnson, D.A., Richardson, T.B., Santarosa, M., Dillon, K.J., Hickson, I., Knights, C., et al. (2005). Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917-921. https://doi.org/10.1038/nature03445
- Hu, C.K., Coughlin, M., Field, C.M., and Mitchison, T.J. (2011). KIF4 regulates midzone length during cytokinesis. Curr. Biol. 21, 815-824. https://doi.org/10.1016/j.cub.2011.04.019
- Huambachano, O., Herrera, F., Rancourt, A., and Satoh, M.S. (2011). Double-stranded DNA binding domain of poly(ADP-ribose) polymerase-1 and molecular insight into the regulation of its activity. J. Biol. Chem. 286, 7149-7160. https://doi.org/10.1074/jbc.M110.175190
- Hydock, D.S., Lien, C.Y., Jensen, B.T., Parry, T.L., Schneider, C.M., and Hayward, R. (2012). Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity. Exp. Biol. Med. 237, 1483-1492. https://doi.org/10.1258/ebm.2012.012137
- Ibragimova, I., and Cairns, P. (2011). Assays for hypermethylation of the BRCA1 gene promoter in tumor cells to predict sensitivity to PARP-inhibitor therapy. Methods Mol. Biol. 780, 277-291. https://doi.org/10.1007/978-1-61779-270-0_17
- Jacot, W., Thezenas, S., Senal, R., Viglianti, C., Laberenne, A.C., Lopez-Crapez, E., Bibeau, F., Bleuse, J.P., Romieu, G., and Lamy, P.J. (2013). BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer. BMC Cancer 13, 523. https://doi.org/10.1186/1471-2407-13-523
- Javle, M., and Curtin, N.J. (2011). The role of PARP in DNA repair and its therapeutic exploitation. Br. J. Cancer 105, 1114-1122. https://doi.org/10.1038/bjc.2011.382
- Langelier, M.F., Planck, J.L., Roy, S., and Pascal, J.M. (2011). Crystal structures of poly(ADP-ribose) polymerase-1 (PARP-1) zinc fingers bound to DNA: structural and functional insights into DNA-dependent PARP-1 activity. J. Biol. Chem. 286, 10690-10701. https://doi.org/10.1074/jbc.M110.202507
- Lee Kraus, W., and Hottiger, M.O. (2013). PARP-1 and gene regulation: progress and puzzles. Mol. Aspects Med. 34, 1109-1123. https://doi.org/10.1016/j.mam.2013.01.005
- Martinez-Romero, R., Canuelo, A., Siles, E., Oliver, F.J., and Martinez-Lara, E. (2012). Nitric oxide modulates hypoxiainducible factor-1 and poly(ADP-ribose) polymerase-1 cross talk in response to hypobaric hypoxia. J. Appl. Physiol. 112, 816-823. https://doi.org/10.1152/japplphysiol.00898.2011
- Midorikawa, R., Takei, Y., and Hirokawa, N. (2006). KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity. Cell 125, 371-383. https://doi.org/10.1016/j.cell.2006.02.039
- Munoz-Gamez, J.A., Martin-Oliva, D., Aguilar-Quesada, R., Canuelo, A., Nunez, M.I., Valenzuela, M.T., Ruiz de Almodovar, J.M., De Murcia, G., and Oliver, F.J. (2005). PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis. Biochem. J. 386, 119-125. https://doi.org/10.1042/BJ20040776
- Oonk, A.M., van Rijn, C., Smits, M.M., Mulder, L., Laddach, N., Savola, S.P., Wesseling, J., Rodenhuis, S., Imholz, A.L., and Lips, E.H. (2012). Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapy. Ann. Oncol. 23, 2301-2305. https://doi.org/10.1093/annonc/mdr621
- Shrestha, S., Wilmeth, L.J., Eyer, J., and Shuster, C.B. (2012). PRC1 controls spindle polarization and recruitment of cytokinetic factors during monopolar cytokinesis. Mol. Biol. Cell 23, 1196-1207. https://doi.org/10.1091/mbc.E11-12-1008
- Stanisavljevic, J., Porta-de-la-Riva, M., Batlle, R., de Herreros, A.G., and Baulida, J. (2011). The p65 subunit of NF-kappaB and PARP1 assist Snail1 in activating fibronectin transcription. J. Cell Sci. 124, 4161-4171. https://doi.org/10.1242/jcs.078824
- Sukowati, C.H., Rosso, N., Pascut, D., Anfuso, B., Torre, G., Francalanci, P., Croce, L.S., and Tiribelli, C. (2012). Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma. BMC Gastroenterol. 12, 160. https://doi.org/10.1186/1471-230X-12-160
- Sun, S., Chen, Z., Li, L., Sun, D., Tian, Y., Pan, H., Bi, H., Huang, M., Zeng, S., and Jiang, H. (2012). The two enantiomers of tetrahydropalmatine are inhibitors of P-gp, but not inhibitors of MRP1 or BCRP. Xenobiotica 42, 1197-1205. https://doi.org/10.3109/00498254.2012.702247
- Villar, V.H., Vogler, O., Martinez-Serra, J., Ramos, R., Calabuig-Farinas, S., Gutierrez, A., Barcelo, F., Martin-Broto, J., and Alemany, R. (2012). Nilotinib counteracts P-glycoproteinmediated multidrug resistance and synergizes the antitumoral effect of doxorubicin in soft tissue sarcomas. PLoS One 7, e37735. https://doi.org/10.1371/journal.pone.0037735
- Wandke, C., Barisic, M., Sigl, R., Rauch, V., Wolf, F., Amaro, A.C., Tan, C.H., Pereira, A.J., Kutay, U., Maiato, H., et al. (2012). Human chromokinesins promote chromosome congression and spindle microtubule dynamics during mitosis. J. Cell Biol. 198, 847-863. https://doi.org/10.1083/jcb.201110060
- Wu, G., Zhou, L., Khidr, L., Guo, X.E., Kim, W., Lee, Y.M., Krasieva, T., and Chen, P.L. (2008). A novel role of the chromokinesin Kif4A in DNA damage response. Cell Cycle 7, 2013-2020. https://doi.org/10.4161/cc.7.13.6130
- Xu, Y., Diao, Y., Qi, S., Pan, X., Wang, Q., Xin, Y., Cao, X., Ruan, J., Zhao, Z., Luo, L., et al. (2013). Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis. Cell. Signal. 25, 1176-1185. https://doi.org/10.1016/j.cellsig.2013.01.017
- Zaremba, T., Thomas, H., Cole, M., Plummer, E.R., and Curtin, N.J. (2010). Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials. Cancer Chemother. Pharmacol. 66, 807-812. https://doi.org/10.1007/s00280-010-1359-0
- Zheng, Z., Aojula, H., and Clarke, D. (2010). Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide. J. Drug Target. 18, 477-487. https://doi.org/10.3109/10611860903548347
Cited by
- Increased anti-tumour activity by exosomes derived from doxorubicin-treated tumour cells via heat stress vol.31, pp.5, 2015, https://doi.org/10.3109/02656736.2015.1036384
- Mitochondria-Derived Reactive Oxygen Species Play an Important Role in Doxorubicin-Induced Platelet Apoptosis vol.16, pp.5, 2015, https://doi.org/10.3390/ijms160511087
- Systematic Identification and Assessment of Therapeutic Targets for Breast Cancer Based on Genome-Wide RNA Interference Transcriptomes vol.8, pp.3, 2017, https://doi.org/10.3390/genes8030086
- Upregulate KIF4A Enhances Proliferation, Invasion of Hepatocellular Carcinoma and Indicates poor prognosis Across Human Cancer Types vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-04176-9
- Enhanced cytotoxic activity of doxorubicin through the inhibition of autophagy in triple negative breast cancer cell line vol.1861, pp.2, 2017, https://doi.org/10.1016/j.bbagen.2016.11.013
- RNA-Seq based genome-wide analysis reveals loss of inter-chromosomal regulation in breast cancer vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-01314-1
- The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells vol.34, pp.4, 2016, https://doi.org/10.1007/s10637-016-0345-8
- HOTAIR upregulates an 18-gene cell cycle-related mRNA network in glioma vol.50, pp.4, 2017, https://doi.org/10.3892/ijo.2017.3901
- Anthocyanin Attenuates Doxorubicin-Induced Cardiomyotoxicity via Estrogen Receptor-α/β and Stabilizes HSF1 to Inhibit the IGF-IIR Apoptotic Pathway vol.17, pp.9, 2016, https://doi.org/10.3390/ijms17091588
- Prognostic genes of breast cancer revealed by gene co-expression network analysis vol.14, pp.4, 2017, https://doi.org/10.3892/ol.2017.6779
- Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics vol.37, pp.7, 2018, https://doi.org/10.1038/onc.2017.406
- A novel PHD-finger protein 14/KIF4A complex overexpressed in lung cancer is involved in cell mitosis regulation and tumorigenesis vol.8, pp.12, 2014, https://doi.org/10.18632/oncotarget.14962
- Gene co-expression network reveals shared modules predictive of stage and grade in serous ovarian cancers vol.8, pp.26, 2014, https://doi.org/10.18632/oncotarget.17785
- Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt’s lymphoma anti-tumor activity vol.8, pp.41, 2017, https://doi.org/10.18632/oncotarget.18215
- Distinct Diagnostic and Prognostic Values of Kinesin Family Member Genes Expression in Patients with Breast Cancer vol.24, pp.None, 2014, https://doi.org/10.12659/msm.913401
- An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer vol.11, pp.None, 2014, https://doi.org/10.2147/ott.s164730
- Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression vol.21, pp.2, 2014, https://doi.org/10.3233/cbm-170501
- Enhanced expression of KIF4A in colorectal cancer is associated with lymph node metastasis vol.15, pp.2, 2014, https://doi.org/10.3892/ol.2017.7555
- Identification of KIF11 As a Novel Target in Meningioma vol.11, pp.4, 2014, https://doi.org/10.3390/cancers11040545
- Overexpression of CDCA5 , KIF4A , TPX2 , and FOXM1 Coregulated Cell Cycle and Promoted Hepatocellular Carcinoma Development vol.27, pp.6, 2014, https://doi.org/10.1089/cmb.2019.0254
- Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer vol.13, pp.None, 2014, https://doi.org/10.1186/s13048-020-0613-2
- Identification of KIF4A as a pan-cancer diagnostic and prognostic biomarker via bioinformatics analysis and validation in osteosarcoma cell lines vol.9, pp.None, 2014, https://doi.org/10.7717/peerj.11455
- Noncovalent Functionalized Graphene Nanocarriers from Graphite for Treating Thyroid Cancer Cells vol.7, pp.6, 2014, https://doi.org/10.1021/acsbiomaterials.1c00067
- Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer vol.11, pp.11, 2014, https://doi.org/10.3390/jpm11111089